113 related articles for article (PubMed ID: 9301716)
1. Peritoneal carcinomatosis with urachal signet-cell adenocarcinoma.
Loggie BW; Fleming RA; Hosseinian AA
Urology; 1997 Sep; 50(3):446-8. PubMed ID: 9301716
[TBL] [Abstract][Full Text] [Related]
2. Critical analysis of 33 patients with peritoneal carcinomatosis secondary to colorectal and appendiceal signet ring cell carcinoma.
Chua TC; Pelz JO; Kerscher A; Morris DL; Esquivel J
Ann Surg Oncol; 2009 Oct; 16(10):2765-70. PubMed ID: 19641972
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma.
Jacks SP; Hundley JC; Shen P; Russell GB; Levine EA
J Surg Oncol; 2005 Aug; 91(2):112-7; discussion 118-9. PubMed ID: 16028284
[TBL] [Abstract][Full Text] [Related]
4. Urachal signet ring cell carcinoma.
Morii A; Furuya Y; Fujiuchi Y; Akashi T; Ishizawa S; Fuse H
Int J Urol; 2007 Apr; 14(4):360-1. PubMed ID: 17470172
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma.
Chua TC; Koh JL; Yan TD; Liauw W; Morris DL
J Surg Oncol; 2009 Aug; 100(2):139-43. PubMed ID: 19544356
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive surgery plus intraperitoneal hyperthermic perfusion is an effective treatment for metastasized malignant mixed mesodermal tumours (MMMT)--report of six cases.
Müller H; Nakchbandi V
Eur J Surg Oncol; 2004 Jun; 30(5):573-7. PubMed ID: 15135489
[TBL] [Abstract][Full Text] [Related]
7. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
[TBL] [Abstract][Full Text] [Related]
8. Hyperthermic intraperitoneal chemoperfusion is an option for treatment of peritoneal carcinomatosis in children.
Reingruber B; Boettcher MI; Klein P; Hohenberger W; Pelz JO
J Pediatr Surg; 2007 Sep; 42(9):E17-21. PubMed ID: 17848227
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin.
Loggie BW; Fleming RA; McQuellon RP; Russell GB; Geisinger KR
Am Surg; 2000 Jun; 66(6):561-8. PubMed ID: 10888132
[TBL] [Abstract][Full Text] [Related]
10. [Cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion for peritoneal carcinomatosis caused by recurrent inflammatory myofibroblastic sarcoma: a case report and review of the literature].
Mátrai Z; Péley G; Kovács T; Rényi VF; Szívós E; Szabó E; Vereczkey I; Török K; Köves I
Orv Hetil; 2006 Jan; 147(4):147-58. PubMed ID: 16515023
[TBL] [Abstract][Full Text] [Related]
11. Urachal signet-cell adenocarcinoma.
Egevad L; Håkansson U; Grabe M; Ehrnstrom R
Scand J Urol Nephrol; 2009; 43(1):88-91. PubMed ID: 18759168
[TBL] [Abstract][Full Text] [Related]
12. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
[TBL] [Abstract][Full Text] [Related]
14. [Intestinal obstruction caused by peritoneal carcinomatosis due to signet ring cell carcinoma of the breast].
Pérez JA; Cardemil B; del Pozo M; Avendaño R
Rev Med Chil; 1995 May; 123(5):617-23. PubMed ID: 8525209
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.
Nesher E; Greenberg R; Avital S; Skornick Y; Schneebaum S
Isr Med Assoc J; 2007 Nov; 9(11):787-90. PubMed ID: 18085034
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
17. Sister Mary Joseph's nodule as the sole presenting sign of gastric signet ring cell adenocarcinoma.
Ioannidis O; Cheva A; Stavrakis T; Paraskevas G; Papadimitriou N; Kakoutis E; Makrantonakis A
Gastroenterol Clin Biol; 2010 Oct; 34(10):565-8. PubMed ID: 20739130
[TBL] [Abstract][Full Text] [Related]
18. Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.
Detroz B; Laurent S; Honoré P; Blaffart F; Limet R; Meurisse M
Acta Chir Belg; 2004 Aug; 104(4):377-83. PubMed ID: 15469146
[TBL] [Abstract][Full Text] [Related]
19. Predictors of peritoneal carcinomatosis in patients with gastric cancer treated at a single institution in Brazil.
Fanelli MF; de Paiva TF; Silva MJ; Benevides CF; Guimarães AP; Gimenes DL; Pinheiro ED; Rinck JA; Nicolau UR; Sanches SM; Mello CA; Dettino AL; Cruz MR; de Melo LM; Formiga MN; de Lima VC; Chinen LT
J Surg Oncol; 2009 Nov; 100(6):452-5. PubMed ID: 19697363
[TBL] [Abstract][Full Text] [Related]
20. [Regularities of relapse and metastasis of signet ring cell carcinoma of the stomach following combined and surgical treatment].
Skoronad VIu; Berdov BA; Loktionova OV
Vopr Onkol; 2007; 53(5):538-43. PubMed ID: 18154117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
